ID: MRFR/HC/2716-HCRR | August, 2017 | Region: Global | 84 pages | Half-Cooked Research Reports
FIGURE 1 Global drug allergy market share by end user, 2016 (%)
Sources: European Academy of Allergy and Clinical Immunology, Asthm
a and Allergy Foundation of America, American Academy of Allergy, Asthma & Immunology, National Center for Biotechnology Information (NCBI), Allergy UK, World Allergy Organization (WAO), Directorate of Industries, annual report, white paper, company presentation
Sources: European Academy of Allergy and Clinical Immunology, Asthma and Allergy Foundation of America, American Academy of Allergy, Asthma & Immunology, National Center for Biotechnology Information (NCBI), Allergy UK, World Allergy Organization (WAO), Directorate of Industries, annual report, white paper, company presentation
Market Synopsis of Global Drug Allergy Market
Drug allergy is one of the most common types of allergies. It is the hyper sensitivity of the immune system to drug or medication. Any types of drugs such as prescription, nonprescription or herbal can induce drug allergy. Some common symptoms of the drug allergies are hives, skin rash, itching of the eyes or skin, swelling of the face, lips, or tongue, wheezing, and others. Treatment can relieve and prevent severe reactions.
Increasing awareness about various allergies, the introduction of the new treatment of products and rising demand from emerging markets drives the growth of the global market. New research to prevent drug allergies is another key driver for the market. The global drug allergy market is growing moderately and is expected to continue its growth over the forecast period.
The global drug allergy market is expected to grow at the CAGR of ~5.1% during the forecast period and is estimated to reach USD 4764.0 million by 2023.
The global drug allergy market is segmented on the basis of type, which comprises of immunologic, nonimmunologic, and others. Immunologic allergy is sub-segmented into type I reaction, type II reaction, type III reaction, type IV reaction, and others. The non-immunologic allergy is sub-segmented into predictable, unpredictable, and others. The predictable allergy is further segmented into pharmacologic side effect, secondary pharmacologic side effect, drug toxicity, drug-drug interactions, drug overdose, and others. The unpredictable segment is further sub-segmented into pseudoallergic, idiosyncratic, intolerance, and others.
On the basis of diagnosis, the market is segmented into skin tests, blood tests, patch test, and others. The skin test is further segmented into prick or scratch test, intradermal test, and others.
On the basis of treatments, the market is segmented into antihistamines, corticosteroids, treatment of anaphylaxis, withdrawal of the drug, and others. Antihistamines are further sub-segmented into azelastine eyedrops, azelastine nasal sprays, carbinoxamine, cyproheptadine, desloratadine, diphenhydramine, emedastine eyedrops, hydroxyzine, levocabastine eyedrops, levocabastine oral, and others. Corticosteroids is further sub-segmented into topical steroids, inhaled steroids, and others. Inhaled steroids is further segmented into flunisolide, fluticasone furoate, fluticasone propionate, triamcinolone acetonide, beclomethasone dipropionate, budesonide, and others.
On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.
Regional Analysis of the Global Drug Allergy Market
The Americas dominate the global market for the drug allergy. The Americas mainly include North America and Latin America, out of which North America accounts for the majority of the market share of this region. The US is the top revenue generating market in North America and is one of the important markets for the global drug allergy treatment. Approximately 10% of the total US population have drug allergies. Latin America drug allergy market is also growing significantly and mainly includes Brazil, Argentina, and Chile. Europe is the second largest market in the globe owing to increasing cases of drug allergy.
Europe is mainly divided into Eastern Europe and Western Europe. More developed Western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Increasing cases of drug allergies are one of the major factors for the growth of the Europe market.
Asia Pacific region is showing the fastest growth rate in the global drug allergy market due to some major factors such as increasing awareness about various drug allergies, availability of treatment products, and rapidly improving healthcare facilities. Japan is holding the major market share while China’s drug allergy market is expected to show the fastest growth in this region. Changing healthcare practices and increasing patient involvement play an important role in the growth of this market.
The Middle East & Africa is expected to experience a limited growth due to lack of awareness about diseases, traditional healthcare practices, etc. The Middle East region dominates the market due to some of the major factors, for instance, developed healthcare facilities and government support to improve public health.
Key Players in the Global Drug Allergy Market
Some of the key players in this market: AstraZeneca (UK), Bayer (US), Circassia (US), HAL Allergy Group (the Netherlands), Johnson & Johnson Services, Inc. (US), MAGNA Pharmaceuticals, Inc. (US), Stallergenes Greer (UK), and others.
1. Report Prologue
2.2 Scope of the Study
2.2.1 Research Objective
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor analysis
5.1 Value chain analysis
5.2 Porters Five Forces analysis
5.3 Demand & Supply: Gap analysis
5.4 Pricing analysis
5.5 Investment Opportunity analysis
5.6 Merger and Acquisition landscape
5.7 Upcoming trends
6. Global Drug allergy Market by Type
6.1.1 Type I reaction
6.1.2 Type I reaction
6.1.3 Type I reaction
6.1.4 Type IV reaction
184.108.40.206 Pharmacologic side effect
220.127.116.11 Secondary pharmacologic side effect
18.104.22.168 Drug toxicity
22.214.171.124 Drug-drug interactions, Drug overdose
126.96.36.199 Pharmacologic side effect
188.8.131.52 Secondary pharmacologic side effect
184.108.40.206 Drug toxicity
220.127.116.11 Drug-drug interactions
18.104.22.168 Drug overdose
7. Global Drug allergy Market by Diagnosis
7.1 Skin test
7.1.1 Prick or scratch test
7.1.2 Intradermal test
7.2 Blood test
7.3 Patch test
8. Global Drug allergy Market by Treatment
8.1.1 Azelastine eyedrops
8.1.2 Azelastine nasal sprays
8.1.7 Emedastine eyedrops
8.1.9 Levocabastine eyedrops
8.1.10 Levocabastine oral
8.2.1 Topical steroids
8.2.2 Inhaled steroids
8.3 Treatment of anaphylaxis
8.4 Withdrawal of the drug
9. Global Drug allergy Market by End User
9.1 Hospital and clinics
9.2 Medical research centers
9.3 Academic institutes
10. Global Drug allergy Market by Region
10.2.1 North America
10.2.1.1 The US
10.2.2 Latin America
10.3.1 Western Europe
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4.4 South Korea
10.4.5 Rest of Asia
10.6 Middle East and Africa
10.6.2 Saudi Arabia
10.6.4 Rest of Middle East and Africa
11. Competitive Landscape
12. Company Profile
13.1 Key findings
13.1.1 From CEO’s viewpoint
13.1.2 Unmet needs of the market
13.2 Key companies to watch
13.3 Prediction of Drug allergy Market